Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04316169
Title Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Medical College of Wisconsin
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST